Search Medical Condition
Please enter condition
Please choose location from dropdown

London, India Clinical Trials

A listing of London, India clinical trials actively recruiting patients volunteers.

RESULTS

Found (421) clinical trials

A Study Evaluating Good Idea on Glucose Homeostasis in a Healthy Population

A crossover design to evaluate the safety and efficacy of GoodIdea TM (trademark) on glucose homeostasis in a healthy population. Eligible participants will be given either the GoodIdea drink or placebo and a standardized meal and will consume both in approximately 15 minutes. Blood will be drawn at several time ...

Phase

0.08 miles

Learn More »

A Study to Evaluate OPTI-BIOME Bacillus Subtilis MB40 on Abdominal Discomfort Gas and Bloating in a Healthy Population

The purpose of this study is to investigate the effects of OPTI-BIOME (Bacillus subtilis MB40), a probiotic supplement, on bloating, gas and abdominal discomfort symptoms in otherwise healthy adults.

Phase

0.08 miles

Learn More »

Efficacy of a LRC (L. Reuteri NCIMB 30242) Capsule on Managing Cholesterol in Adults

To investigate the effect of a supplement capsule containing LRC (L. reuteri NCIMB 30242), taken twice daily with lunch and dinner (NLT 2.5E9 CFU per dose), versus placebo capsule on serum low density lipoprotein (LDL)-cholesterol in otherwise healthy hypercholesterolemic adults after 9 weeks of product consumption.

Phase N/A

0.08 miles

Learn More »

A Clinical Trial on the Efficacy of a Combination Herbal Product Biotropics' Nu Femme on Menopausal Symptoms and Quality of Life in Women

The purpose of this study is to assess the effectiveness of an herbal combination product called Nu Femme, on menopausal symptoms in peri-menopausal women.

Phase

0.08 miles

Learn More »

Effect of Efpeglenatide on Cardiovascular Outcomes

The estimated study duration per participant is up to approximately 36 months.

Phase

0.08 miles

Learn More »

Ability of a Euglena Beta Glucan Supplementation to Augment Immune Function

At screening, an informed consent form will be given to the potential volunteer. They will be required to read the information and be given the opportunity to seek more information if needed, or provided with the option of taking the consent form home to review prior to making their decision. ...

Phase N/A

0.08 miles

Learn More »

AMAZ-02 Effect on Exercise ToLerance in Healthy Overweight Middle Aged Subjects (ATLAS Trial)

This is a Phase 2 randomized, double-blind, placebo-controlled study enrolling 90 healthy, overweight, middle aged subjects (30 placebo, 30 low dose and 30 high dose AMAZ-02 intervention), 40-65 years of age, who are otherwise healthy. AMAZ-02, a food derived ingredient, will be given as a daily oral dose for 4 ...

Phase N/A

0.08 miles

Learn More »

A Study to Evaluate the Efficacy of the Investigational Products on Complete Spontaneous Bowel Movements in Participants Who Normally Have 3 Complete Spontaneous Bowel Movements Per Week But Are Otherwise Healthy

Low and High doses of Actazin and Livaux will be compared against a control formula and placebo to evaluate how each investigational study product effects complete spontaneous bowel movements in healthy adults that currently experience less than or equal to 3 complete spontaneous bowel movements per week. During the 28-day ...

Phase

0.08 miles

Learn More »

Phase 2b Study in NASH to Assess IVA337

Randomized (stratified on diabetes), placebo-controlled, double-blind, parallel-assignment, dose-range multicenter study There are 3 parallel treatment groups: placebo, IVA337 800mg once a day (Quaque Die, QD) and IVA337 1200mg QD (identical tablets of 400mg IVA337 or placebo). Both, patient and investigator are blinded. For each patient, the study duration will be ...

Phase

0.12 miles

Learn More »

Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)

The purpose of this study is to determine the efficacy and safety of pembrolizumab given concomitantly with chemoradiation (CRT) and as maintenance therapy versus placebo plus CRT in participants with locally advanced head and neck squamous cell carcinoma (LA HNSCC). The primary hypothesis is that pembrolizumab in combination with CRT ...

Phase

0.12 miles

Learn More »